Mild Cognitive Impairment: Quantifying a Qualitative Disorder

Kevin Duff1

  • 1Department of Neurology, Layton Aging & Alzheimer's Disease Research Center, Oregon Health & Science University, 3181 Southwest Sam Jackson Park Road (Mail code: CR131), Portland, OR 97239, USA.

Neurologic Clinics
|September 29, 2024
PubMed

Insights

Mild cognitive impairment (MCI) is a transitional stage between normal aging and dementia. Quantitative methods offer a way to track cognitive changes and assess interventions for this condition.

Area of Science:

  • Neurology
  • Gerontology
  • Cognitive Science

Background:

  • Mild cognitive impairment (MCI) represents a critical transitional phase between normal cognitive aging and dementia.
  • MCI is characterized by subjective cognitive complaints, objective cognitive deficits, and preserved daily functioning.

Purpose of the Study:

  • To explore the role of quantitative methods in identifying and tracking mild cognitive impairment.
  • To evaluate the potential of quantitative approaches in assessing interventions for individuals with MCI.

Main Methods:

  • Utilizing qualitative and quantitative perspectives for MCI identification and monitoring.
  • Applying objective cognitive assessments to track subtle changes over time.

Main Results:

  • MCI progression to dementia is frequent, though stability and reversion to normal cognition are also observed.
  • Quantitative methods provide a means to evaluate subtle cognitive declines in MCI.

Conclusions:

  • Quantitative methods are valuable tools for healthcare providers in managing and studying mild cognitive impairment.
  • These methods can aid in assessing the efficacy of interventions aimed at mitigating MCI progression.

Related Concept Videos

Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
65
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
451
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
99
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
106
Intellectual Disability01:29

Intellectual Disability

Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
44